BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 38357171)

  • 1. Editor's choice: Sexual reproductive health, child issues, NCDs, surgery, infections and health systems - a salad of sorts.
    Tumwine JK
    Afr Health Sci; 2023 Sep; 23(3):i-vi. PubMed ID: 38357140
    [No Abstract]   [Full Text] [Related]  

  • 2. 'Triple negative' epithelial ovarian cancer and pathologic markers for prognosis.
    Liu N; Wang X; Sheng X
    Curr Opin Obstet Gynecol; 2011 Feb; 23(1):19-23. PubMed ID: 21150601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological pattern of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 over-expression of epithelial ovarian carcinomas in Nigeria.
    Ajani MA; Lawan A; Oke T; Khramtsova G; Nwanji I; Salami A; Awolude O; Ebili H; Onwukamuche ME; Sveen E; Yoshimatsu T; Olopade OI
    Afr Health Sci; 2023 Sep; 23(3):236-244. PubMed ID: 38357171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study.
    Sieh W; Köbel M; Longacre TA; Bowtell DD; deFazio A; Goodman MT; Høgdall E; Deen S; Wentzensen N; Moysich KB; Brenton JD; Clarke BA; Menon U; Gilks CB; Kim A; Madore J; Fereday S; George J; Galletta L; Lurie G; Wilkens LR; Carney ME; Thompson PJ; Matsuno RK; Kjær SK; Jensen A; Høgdall C; Kalli KR; Fridley BL; Keeney GL; Vierkant RA; Cunningham JM; Brinton LA; Yang HP; Sherman ME; García-Closas M; Lissowska J; Odunsi K; Morrison C; Lele S; Bshara W; Sucheston L; Jimenez-Linan M; Driver K; Alsop J; Mack M; McGuire V; Rothstein JH; Rosen BP; Bernardini MQ; Mackay H; Oza A; Wozniak EL; Benjamin E; Gentry-Maharaj A; Gayther SA; Tinker AV; Prentice LM; Chow C; Anglesio MS; Johnatty SE; Chenevix-Trench G; Whittemore AS; Pharoah PD; Goode EL; Huntsman DG; Ramus SJ
    Lancet Oncol; 2013 Aug; 14(9):853-62. PubMed ID: 23845225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone-receptor expression status of epithelial ovarian cancer in Ibadan, South-western Nigeria.
    Ajani MA; Salami A; Awolude OA; Oluwasola AO
    Pan Afr Med J; 2017; 27():259. PubMed ID: 29187928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinicopathological characteristics of 'triple-negative' epithelial ovarian cancer.
    Liu N; Wang X; Sheng X
    J Clin Pathol; 2010 Mar; 63(3):240-3. PubMed ID: 20203223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern of hormone receptors and human epidermal growth factor receptor 2 status in sub-Saharan breast cancer cases: Private practice experience.
    Nwafor CC; Keshinro SO
    Niger J Clin Pract; 2015; 18(4):553-8. PubMed ID: 25966732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian cancer statistics, 2018.
    Torre LA; Trabert B; DeSantis CE; Miller KD; Samimi G; Runowicz CD; Gaudet MM; Jemal A; Siegel RL
    CA Cancer J Clin; 2018 Jul; 68(4):284-296. PubMed ID: 29809280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation Between Immunohistochemical Biomarkers Expression and Prognosis of Ovarian Carcinomas in Tunisian Patients.
    Ayadi L; Chaabouni S; Khabir A; Amouri H; Makni S; Guermazi M; Frikha M; Boudawara TS
    World J Oncol; 2010 Jun; 1(3):118-128. PubMed ID: 29147191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of ovarian cancer: a review.
    Reid BM; Permuth JB; Sellers TA
    Cancer Biol Med; 2017 Feb; 14(1):9-32. PubMed ID: 28443200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone receptor, HER2/NEU and EGFR expression in ovarian carcinoma--is here a prognostic phenotype?
    Demir L; Yigit S; Sadullahoglu C; Akyol M; Cokmert S; Kucukzeybek Y; Alacacioglu A; Cakalagaoglu F; Tarhan MO
    Asian Pac J Cancer Prev; 2014; 15(22):9739-45. PubMed ID: 25520097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian cancer.
    Jayson GC; Kohn EC; Kitchener HC; Ledermann JA
    Lancet; 2014 Oct; 384(9951):1376-88. PubMed ID: 24767708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the contribution of immunologically-detectable HER2, steroid receptors and of the "triple-negative" tumor status to disease-free and overall survival of women with epithelial ovarian cancer.
    de Toledo MC; Sarian LO; Sallum LF; Andrade LL; Vassallo J; de Paiva Silva GR; Pinto GA; Soares FA; Fonseca CD; Derchain SF
    Acta Histochem; 2014 Apr; 116(3):440-7. PubMed ID: 24238473
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.